MolDX: Tests on Allograft Kidney Biopsy Tissue to Assess for Graft Rejection Proposed LCD Retirement; Billing and Coding: MolDX: Tests on Allograft Kidney Biopsy Tissue to Assess for Graft Rejection - Effective September 09, 2020

This proposed Local Coverage Determination (LCD) has been retired under contractor 01112 (NCA), 01182 (SCA), 01212 (AS, GU, HI, NMI), and 01312 (NV). 

Medicare Coverage Database (MCD) Number: DL38319/DA57286
LCD Title: MolDX: Tests on Allograft Kidney Biopsy Tissue to Assess for Graft Rejection
LCA Title: Billing and Coding: MolDX: Tests on Allograft Kidney Biopsy Tissue to Assess for Graft Rejection
Effective Date: September 09, 2020

LCDs and LCAs are retired due to lack of evidence of current need(s) for the education and/or edits or in some cases because the material is addressed by a National Coverage Determination (NCD), a coverage provision in a CMS interpretative manual, another LCD or an article. Retirement does not mean that medical necessity has changed or that the LCD no longer reflects appropriate criteria. The guidance in the retired LCD may be helpful in assessing medical necessity.

To access retired proposed LCDs, visit the CMS Medicare Coverage Database Archive.

Visit the Noridian Medicare Coverage Articles webpage to access the Retired articles in the CMS MCD.

 

            Last Updated Fri, 18 Sep 2020 17:11:12 +0000